Developing a support needs approach for patients (SNAP2)

Accessing and delivering person-centred care in advanced non-cancer conditions: Developing and piloting a Support Needs Approach for Patients (SNAP) with advanced COPD

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN29580717

Enrollment

248

Registered

2017-06-08

Start date

2017-06-12

Completion date

Unknown

Last updated

2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Specialty: Primary Care, Primary sub-specialty: Respiratory disorders

Interventions

Stage 1: SNAP Tool Validation The first stage involves two tasks. The first task is the initial validation of the SNAP tool. As a patient-completed tool, face validity is essential. As

the tool should be significantly related to how the patient feels and underlying illness burden (impact). Patients are recruited from primary care. The survey booklet contains the SNAP tool, standard

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Stage 1: Adult patients with COPD who meet two or more of these inclusion criteria: 1. FEV1< 30% 2. 2+ exacerbations requiring prednisolone and antibiotics in previous year 3. Admission for COPD in previous 2 years 4. Long-term oxygen therapy 5. Cor pulmonale 6. MRC dyspnea scale 4+ Stage 2: 1. Healthcare professionals working at pilot study clinical sites who deliver (or facilitate delivery of) the SNAP intervention 2. Patients with COPD registered with pilot study clinical sites and who receive the SNAP intervention 3. Aged 18 and older

Exclusion criteria

Exclusion criteria: For both Stage 1 and 2: 1. Serious mental health problem 2. Serious learning difficulty 3. Unable to give informed consent

Design outcomes

Primary

Measure	Time frame
Stage 1: 1. Face validity and initial content validity of the SNAP tool is assessed using patient and carer focus groups. 2. Content and criterion validity of the SNAP tool (includes SNAP tool plus quality of life, COPD impact and anxiety and depression measures) is assessed through patient self-completion of the postal survey 3. Quality of life in chronic lung disease is measured using the Chronic Respiratory Questionnaire (CRQ) at time of the survey 4. COPD impact is measured using the COPD Assessment Test (CAT) at time of the survey 5. Presence of depression and anxiety is measured using the Hospital Depression and Anxiety Scale (HADS) at time of survey Stage 2: 1. HCP SNAP tool use and barriers to SNAP implementation are assessed using semi-structured telephone interviews at month one, two, three and four 2. Patient experiences of SNAP (i.e. what was the tool like to complete, any missing items, how did HCPs use and respond to the tool, and how was this different to usual care) are assessed using face to face semi-structured interviews at month one to four 3. HCP experiences of SNAP (including working with the tool, and barriers/facilitators to SNAP implementation) are assessed using focus groups following month four	—

Measure

Time frame

Stage 1: 1. Face validity and initial content validity of the SNAP tool is assessed using patient and carer focus groups. 2. Content and criterion validity of the SNAP tool (includes SNAP tool plus quality of life, COPD impact and anxiety and depression measures) is assessed through patient self-completion of the postal survey 3. Quality of life in chronic lung disease is measured using the Chronic Respiratory Questionnaire (CRQ) at time of the survey 4. COPD impact is measured using the COPD Assessment Test (CAT) at time of the survey 5. Presence of depression and anxiety is measured using the Hospital Depression and Anxiety Scale (HADS) at time of survey Stage 2: 1. HCP SNAP tool use and barriers to SNAP implementation are assessed using semi-structured telephone interviews at month one, two, three and four 2. Patient experiences of SNAP (i.e. what was the tool like to complete, any missing items, how did HCPs use and respond to the tool, and how was this different to usual care) are assessed using face to face semi-structured interviews at month one to four 3. HCP experiences of SNAP (including working with the tool, and barriers/facilitators to SNAP implementation) are assessed using focus groups following month four

—

Secondary

Measure	Time frame
There are no secondary outcome measures for both stage one and two.	—

Countries

England, United Kingdom

Contacts

Public ContactMorag Farquhar

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026